You are here

Article Text

Article menu
Download PDFPDF
Leading article
Fibrosis progression in chronic hepatitis C virus infection
  1. G W McCaughan1,
  2. J George2
  1. 1NHMRC Clinical Centre of Research Excellence in Outcomes for Chronic Liver Disease, and AW Morrow Gastroenterology and Liver Centre, Centenary Research Institute, University of Sydney, Royal Prince Alfred Hospital, Sydney, Australia
  2. 2NHMRC Clinical Centre of Research Excellence in Outcomes for Chronic Liver Disease, and Storr Liver Unit, Millennium Research Centre, University of Sydney, Royal Prince Alfred Hospital, Sydney, Australia
  1. Correspondence to:
    Professor G W McCaughan
    AW Morrow Gastroenterology and Liver Centre, Centenary Research Institute, Missenden Rd, Royal Prince Alfred Hospital, Camperdown NSW 2050, Australia; g.mccaughancentenary.usyd.edu.au

Abstract

Chronic hepatitis C virus infection is typically characterised by slowly progressive hepatic fibrosis. However, it is recognised that some patients do not progress while others rapidly develop significant fibrosis. Here, we review studies that have assessed factors that could influence this rate of fibrotic progression.

  • hepatitis C virus
  • fibrosis
  • HCV, hepatitis C virus
  • HSC, hepatic stellate cell
  • IR, insulin resistance
  • CHC, chronic hepatitis C
  • TNF, tumour necrosis factor
  • PPAR, peroxisome proliferator activated receptor
  • IFN-γ, interferon γ
  • TGF-β, transforming growth factor β

https://doi.org/10.1136/gut.2003.026393

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    Linked Articles